3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Conditions
Neoplasms
4
Heart Diseases
3
Carcinoma, Non-Small-Cell Lung
3
Vascular Diseases
2
Cardiotoxicity
2
Small Cell Lung Carcinoma
1
Metabolic Diseases
1
Liver Neoplasms
1
Heart Failure
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Cardiovascular Diseases
1
Cancer Therapy-related Cardiovascular Toxicity
1
Interventions
Echocardiography
11
Electrocardiography
5
Trastuzumab
4
Social Determinants of Health
2
Doxorubicin
2
Chemoradiotherapy
2
Blood Specimen Collection
2
Antineoplastic Agents
2
Vascular Stiffness
1
Standard of Care
1
Resistance Training
1
Pulse Wave Analysis
1
Positron Emission Tomography Computed Tomography
1
Magnetic Resonance Spectroscopy
1
Immunomodulating Agents
1
Hematologic Tests
1
Gonadal Steroid Hormones
1
Exercise Test
1
EGFR tyrosine kinase inhibitor 324674
1
Clinical Laboratory Techniques
1
Cisplatin
1
Cardiography, Impedance
1
Anthracyclines
1
Amplified Fragment Length Polymorphism Analysis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Cardiotoxicity
×
Antineoplastic Agents
×
Clear all
NCT03882580
2023-04-24
NEOCARDIO
Groupe Hospitalier Pitie-Salpetriere
Unknown
5,000 enrolled
NCT03530215
2023-04-13
EROCA
Groupe Hospitalier Pitie-Salpetriere
Completed
500,000 enrolled